Article Download
Overview of Using Flow Cytometry for Developing Better Lead Candidates
To maximize the chances that a therapeutic candidate is successful in clinical trials, rapid and accurate lead identification and characterization are critical. Traditional screening assays are limited in their ability to replicate and measure biological context and can often measure only one parameter at a time. With its flexilbity, throughput, ability to measure multiple parameters simultaneously, and compatibility with live cells, flow cytometry can solve these challenges and is growing in popularity for lead candidate screening.
Read this article to learn about:
- How flow cytometry facilitates cell-based primary screens, preserving biological context for drug activity
- Why the ability to measure multiple parameters matters for both primary and secondary screens
- What to look for when selecting a flow cytometer for your lead candidate screening needs
Download the Article
Share a little information with us to access the entire article now.
Content you'll also find interesting
Recommended Features
-
Image
Using Flow Cytometry to Advance Therapeutic Antibody Development
Rapid, accurate lead candidate identification is easy with the right tools. We describe the benefits of using flow cytometry to perform cell-based assays.
-
Image
Maximizing Screening Speed and Throughput with Flow Cytometry
This infographic highlights challenges for high-throughput flow cytometry and how the ZE5 Cell Analyzer has solutions to overcome them.
-
Image
Methods to Monitor Antibody Immune Responses Against Biotherapeutic Drugs
Discover how anti-idiotypic antibodies can help overcome the challenges involved in the development of bioanalytical assays to monitor antibody drug candidates.
